EPHA3 and neoplasm: EphA3 targeted [64Cu]Cu-IIIA4 PET/CT imaging revealed specific tumor uptake in an orthotopic GB model and IIIA4 conjugated to maytansine induced a potent GB anti-tumor response [336].